Cover Image
市場調查報告書

Metabolic Solutions Development Company, LLC 產品平台分析

Metabolic Solutions Development Company, LLC - Product Pipeline Review - 2014

出版商 Global Markets Direct 商品編碼 318948
出版日期 內容資訊 英文 23 Pages
訂單完成後即時交付
價格
Back to Top
Metabolic Solutions Development Company, LLC 產品平台分析 Metabolic Solutions Development Company, LLC - Product Pipeline Review - 2014
出版日期: 2014年11月14日 內容資訊: 英文 23 Pages
簡介

Metabolic Solutions Development Company, LLC 是發現針對代謝疾病用分子標的及開發治療藥的藥物研發企業。開發中產品有口服胰島素敏化劑,第二型糖尿病患者的胰島素抗性治療藥等。

本報告提供Metabolic Solutions Development Company, LLC 的治療藥開發平台現狀及各開發階段比較分析,提供您藥物標的,作用機制,給藥途徑,各分子類型的治療藥評估,最新的企業新聞和發表,後期階段及中止的計劃等相關資訊。

目錄

Metabolic Solutions Development Company, LLC 基本資料

  • Metabolic Solutions Development Company, LLC 概要
  • 主要資訊
  • 企業資料

Metabolic Solutions Development Company, LLC :R&D概要

  • 主要的治療範圍

Metabolic Solutions Development Company, LLC :開發平台評估

  • 各開發階段的開發中產品
  • 單劑產品

Metabolic Solutions Development Company, LLC :開發中產品概況

  • 臨床階段的開發中產品
    • 第二階段的產品/聯合治療模式
  • 初期階段的開發中產品
    • 前臨床階段的產品/聯合治療模式
    • 藥物研發階段的產品/聯合治療模式

Metabolic Solutions Development Company, LLC :藥物簡介

  • MSDC-0160
  • MSDC-0602
  • Small Molecules for Type-2 Diabetes

Metabolic Solutions Development Company, LLC :開發平台分析

  • 各給藥途徑
  • 各分子類型

Metabolic Solutions Development Company, LLC :最新的開發平台資訊

Metabolic Solutions Development Company, LLC :總公司和子公司的所在地

  • 總公司

附錄

圖表一覽

目錄
Product Code: GMDHC06504CDB

Summary

Global Markets Direct's, 'Metabolic Solutions Development Co. - Product Pipeline Review - 2014', provides an overview of the Metabolic Solutions Development Co.'s pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of Metabolic Solutions Development Co.'s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides brief overview of Metabolic Solutions Development Co. including business description, key information and facts, and its locations and subsidiaries
  • The report reviews current pipeline of Metabolic Solutions Development Co.'s human therapeutic division and enlists all their major and minor projects
  • The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones
  • Special feature on out-licensed and partnered product portfolio
  • The report summarizes all the dormant and discontinued pipeline projects
  • Latest company statement
  • Latest news and deals relating to the Metabolic Solutions Development Co.'s pipeline products

Reasons to buy

  • Evaluate Metabolic Solutions Development Co.'s strategic position with total access to detailed information on its product pipeline
  • Assess the growth potential of Metabolic Solutions Development Co. in its therapy areas of focus
  • Identify new drug targets and therapeutic classes in the Metabolic Solutions Development Co.'s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
  • Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
  • Develop strategic initiatives by understanding the focus areas of Metabolic Solutions Development Co. and exploit collaboration and partnership opportunities
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Plan mergers and acquisitions effectively by identifying the most promising pipeline of Metabolic Solutions Development Co.
  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
  • Explore the dormant and discontinued projects of Metabolic Solutions Development Co. and identify potential opportunities in those areas
  • Avoid Intellectual Property Rights related issues

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Metabolic Solutions Development Company, LLC Snapshot
    • Metabolic Solutions Development Company, LLC Overview
    • Key Information
    • Key Facts
  • Metabolic Solutions Development Company, LLC - Research and Development Overview
    • Key Therapeutic Areas
  • Metabolic Solutions Development Company, LLC - Pipeline Review
    • Pipeline Products by Stage of Development
    • Pipeline Products - Monotherapy
  • Metabolic Solutions Development Company, LLC - Pipeline Products Glance
    • Metabolic Solutions Development Company, LLC - Clinical Stage Pipeline Products
      • Phase II Products/Combination Treatment Modalities
    • Metabolic Solutions Development Company, LLC - Early Stage Pipeline Products
      • Preclinical Products/Combination Treatment Modalities
      • Discovery Products/Combination Treatment Modalities
  • Metabolic Solutions Development Company, LLC - Drug Profiles
    • MSDC-0160
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • MSDC-0602
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • Small Molecules for Type-2 Diabetes
      • Product Description
      • Mechanism of Action
      • R&D Progress
  • Metabolic Solutions Development Company, LLC - Pipeline Analysis
    • Metabolic Solutions Development Company, LLC - Pipeline Products by Route of Administration
    • Metabolic Solutions Development Company, LLC - Pipeline Products by Molecule Type
  • Metabolic Solutions Development Company, LLC - Recent Pipeline Updates
  • Metabolic Solutions Development Company, LLC - Locations And Subsidiaries
    • Head Office
  • Appendix
    • Methodology
    • Coverage
    • Secondary Research
    • Primary Research
    • Expert Panel Validation
    • Contact Us
    • Disclaimer

List of Tables

  • Metabolic Solutions Development Company, LLC, Key Information
  • Metabolic Solutions Development Company, LLC, Key Facts
  • Metabolic Solutions Development Company, LLC - Pipeline by Indication, 2014
  • Metabolic Solutions Development Company, LLC - Pipeline by Stage of Development, 2014
  • Metabolic Solutions Development Company, LLC - Monotherapy Products in Pipeline, 2014
  • Metabolic Solutions Development Company, LLC - Phase II, 2014
  • Metabolic Solutions Development Company, LLC - Preclinical, 2014
  • Metabolic Solutions Development Company, LLC - Discovery, 2014
  • Metabolic Solutions Development Company, LLC - Pipeline by Route of Administration, 2014
  • Metabolic Solutions Development Company, LLC - Pipeline by Molecule Type, 2014
  • Metabolic Solutions Development Company, LLC - Recent Pipeline Updates, 2014

List of Figures

  • Metabolic Solutions Development Company, LLC - Pipeline by Top 10 Indication, 2014
  • Metabolic Solutions Development Company, LLC - Pipeline by Stage of Development, 2014
  • Metabolic Solutions Development Company, LLC - Monotherapy Products in Pipeline, 2014
  • Metabolic Solutions Development Company, LLC - Pipeline by Top 10 Route of Administration, 2014
  • Metabolic Solutions Development Company, LLC - Pipeline by Top 10 Molecule Type, 2014
Back to Top